ABSTRACT
Recently, a mass spectrometry-based approach was introduced to directly assess the IgG1 immunoglobulin clonal repertoires in plasma. Here we expanded upon this approach by describing a mass spectrometry-based technique to assess specifically the clonal repertoire of another important class of immunoglobulin molecules, IgA1, and show it is efficiently and robustly applicable to either milk or plasma samples. Focusing on two individual healthy donors, whose milk was sampled longitudinally during the first 16 weeks of lactation, we demonstrate that the total repertoire of milk sIgA1 is dominated by only 50-500 clones, even though the human body theoretically can generate several orders of magnitude more clones. We show that in each donor the sIgA1 repertoire only changes marginally and quite gradually over the monitored 16-week period of lactation. Furthermore, the observed overlap in clonal repertoires between the two individual donors is close to non-existent. Mothers provide protection to their newborn infants directly by the transfer of antibodies via breastfeeding. The approach introduced here, can be used to visualize the clonal repertoire transferred from mother to infant and to detect changes in-time in that repertoire adapting to changes in maternal physiology.
Subject(s)
Immunoglobulin A, Secretory/immunology , Mass Spectrometry , Milk, Human/immunology , Proteome/immunology , Proteomics , Breast Milk Expression , Chromatography, High Pressure Liquid , Chromatography, Reverse-Phase , Colostrum/immunology , Colostrum/metabolism , Female , Humans , Immunoglobulin A, Secretory/blood , Lactation , Milk, Human/metabolismABSTRACT
We previously showed that supplementation of a high fat diet with paramylon (PM) reduces the postprandial glucose rise, serum total and LDL cholesterol levels, and abdominal fat accumulation in mice. The purpose of this study was to explore the underlying mechanism of PM using microarray analysis. Male mice (C57BL/BL strain) were fed an experimental diet (50% fat energy) containing 5% PM isolated from Euglena gracilis EOD-1 for 12 weeks. After confirming that PM had an improving effect on lipid metabolism, we assessed ileal and hepatic mRNA expression using DNA microarray and subsequent analysis by gene ontology (GO) classification and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. The results suggested that dietary supplementation with PM resulted in decreased abdominal fat accumulation and serum LDL cholesterol concentrations via suppression of the digestion and absorption pathway in the ileum and activation of the hepatic PPAR signaling pathway. Postprandial glucose rise was reduced in mice fed PM, whereas changes in the glucose metabolism pathway were not detected in GO classification and KEGG pathway analysis. PM intake might enhance serum secretory immunoglobulin A concentrations via promotion of the immunoglobulin production pathway in the ileum.
Subject(s)
Dietary Supplements , Glucans/administration & dosage , Ileum/metabolism , Lipid Metabolism , Liver/metabolism , Obesity/metabolism , Abdominal Fat/metabolism , Animals , Blood Glucose/metabolism , Body Weight , Diet , Eating , Euglena gracilis/chemistry , Gene Expression Regulation , Gene Ontology , Glucans/chemistry , Glucans/isolation & purification , Glucans/pharmacology , Immunoglobulin A, Secretory/blood , Lipids/blood , Male , Metabolic Networks and Pathways/genetics , Mice , Mice, Inbred C57BL , Oligonucleotide Array Sequence Analysis , Organ Size , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction/geneticsABSTRACT
INTRODUCTION AND OBJECTIVE: Performing indoor and outdoor work in cold environments may result in various adverse effects on human health and may lead to increased risk of respiratory infection. The aim of this study was to determine the relation of vitamin D status to secretory immunoglobulin A concentration, leucocyte counts, cytokine concentrations and incidence of upper respiratory tract infection (URTI) episodes in young active men during an autumn-winter period. MATERIAL AND METHODS: The effect of work in a cold microclimate was studied among 23 young active male ice hockey players during a 19-week study period. Blood and saliva samples were collected 7 times during the study period. Incidence of URTI was evaluated using WURSS 21. White blood cell, neutrophil, lymphocyte, monocyte, eosinophil and basophil counts, concentrations of 25(OH)D, C-reactive protein, cortisol, IL-1ra, IL-10, IL-1ß and immunoglobulins A, M and G, were determined in the blood. Secretory immunoglobulin A, A1 and A2 and cortisol were analysed in saliva. Spearman's correlations were used to evaluate relationships between initial or final 25(OH)D concentration and URTI incidence, as well as the immune and endocrine markers. Differences in URTI episodes, immune and endocrine parameters between sufficient ( ≥20 ng·ml -1) and deficient (<20 ng ·ml -1) vitamin D status groups were compared with the Mann-Whitney test. RESULTS: There were no statistically significant correlations between mucosal and blood markers or URTI incidence and initial and final 25(OH)D concentrations. Immune, endocrine and URTI variables did not differ between deficient and sufficient vitamin D status groups. CONCLUSIONS: 25(OH)D concentration has no impact on mucosal and systemic immunity, nor on URTI episodes.
Subject(s)
Respiratory Tract Infections/blood , Vitamin D/blood , Adolescent , Adult , C-Reactive Protein/metabolism , Cold Temperature , Cytokines/blood , Humans , Hydrocortisone/blood , Immunoglobulin A, Secretory/blood , Incidence , Male , Poland/epidemiology , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/immunology , Saliva/chemistry , Seasons , Young AdultABSTRACT
OBJECTIVE: To investigate structural and quantitative alterations of gut microbiota in an experimental model of small bowel obstruction. METHOD: A rat model of small bowel obstruction was established by using a polyvinyl chloride ring surgically placed surrounding the terminal ileum. The alterations of gut microbiota were studied after intestinal obstruction. Intraluminal fecal samples proximal to the obstruction were collected at different time points (24, 48 and 72 hours after obstruction) and analyzed by 16s rDNA high-throughput sequencing technology and quantitative PCR (qPCR) for target bacterial groups. Furthermore, intestinal claudin-1 mRNA expression was examined by real-time polymerase chain reaction analysis, and serum sIgA, IFABP and TFF3 levels were determined by enzyme-linked immunosorbent assay. RESULTS: Small bowel obstruction led to significant bacterial overgrowth and profound alterations in gut microbiota composition and diversity. At the phylum level, the 16S rDNA sequences showed a marked decrease in the relative abundance of Firmicutes and increased abundance of Proteobacteria, Verrucomicrobia and Bacteroidetes. The qPCR analysis showed the absolute quantity of total bacteria increased significantly within 24 hours but did not change distinctly from 24 to 72 hours. Further indicators of intestinal mucosa damage and were observed as claudin-1 gene expression, sIgA and TFF3 levels decreased and IFABP level increased with prolonged obstruction. CONCLUSION: Small bowel obstruction can cause significant structural and quantitative alterations of gut microbiota and induce disruption of gut mucosa barrier.
Subject(s)
Gastrointestinal Microbiome/genetics , Ileum/microbiology , Ileum/pathology , Intestinal Obstruction/microbiology , Animals , Bacteroidetes/genetics , Claudin-1/genetics , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , DNA, Ribosomal/genetics , DNA, Ribosomal/isolation & purification , Disease Models, Animal , Feces/microbiology , Firmicutes/genetics , Gene Expression , Immunoglobulin A, Secretory/blood , Immunoglobulin A, Secretory/metabolism , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Intestinal Obstruction/blood , Male , Phylogeny , Proteobacteria/genetics , RNA, Ribosomal, 16S/genetics , Rats , Rats, Wistar , Verrucomicrobia/geneticsABSTRACT
The prebiotic effect of high ß-glucan barley (HGB) flour on the innate immune system of high-fat model mice was investigated. C57BL/6J male mice were fed a high-fat diet supplemented with HGB flour for 90 days. Secretory immunoglobulin A (sIgA) in the cecum and serum were analyzed by enzyme-linked immunosorbent assays (ELISA). Real-time PCR was used to determine mRNA expression levels of pro- and anti-inflammatory cytokines such as interleukin (IL)-10 and IL-6 in the ileum as well as the composition of the microbiota in the cecum. Concentrations of short-chain fatty acids (SCFAs) and organic acids were analyzed by GC/MS. Concentrations of sIgA in the cecum and serum were increased in the HGB group compared to the control. Gene expression levels of IL-10 and polymeric immunoglobulin receptor (pIgR) significantly increased in the HGB group. HGB intake increased the bacterial count of microbiota, such as Bifidobacterium and Lactobacillus. Concentrations of propionate and lactate in the cecum were increased in the HGB group, and a positive correlation was found between these organic acids and the IL-10 expression level. Our findings showed that HGB flour enhanced immune function such as IgA secretion and IL-10 expression, even when the immune system was deteriorated by a high-fat diet. Moreover, we found that HGB flour modulated the gut microbiota, which increased the concentration of SCFAs, thereby stimulating the immune system.
Subject(s)
Cecum/immunology , Flour , Hordeum , Ileum/immunology , Obesity/immunology , Prebiotics , beta-Glucans/analysis , Animals , Bacterial Load , Body Weight , Carboxylic Acids/analysis , Cecum/chemistry , Cecum/microbiology , Cytokines/genetics , Cytokines/metabolism , Diet , Eating , Fatty Acids, Volatile/analysis , Feces/chemistry , Gastrointestinal Microbiome , Gene Expression Profiling , Ileum/metabolism , Immunoglobulin A, Secretory/analysis , Immunoglobulin A, Secretory/blood , Male , Mice , Mice, Inbred C57BL , Organ Size , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Polymeric Immunoglobulin/genetics , Receptors, Polymeric Immunoglobulin/metabolismABSTRACT
A substantial proportion of patients with common variable immunodeficiency (CVID) have inflammatory and autoimmune complications of unknown etiology. We have previously shown that systemic inflammation in CVID correlates with their gut microbial dysbiosis. The gut microbiota dependent metabolite trimethylamine N-oxide (TMAO) has been linked to several metabolic and inflammatory disorders, but has hitherto not been investigated in relation to CVID. We hypothesized that TMAO is involved in systemic inflammation in CVID. To explore this, we measured plasma concentrations of TMAO, inflammatory markers, and lipopolysaccharide (LPS) in 104 CVID patients and 30 controls. Gut microbiota profiles and the bacterial genes CutC and CntA, which encode enzymes that can convert dietary metabolites to trimethylamine in the colon, were examined in fecal samples from 40 CVID patients and 86 controls. Furthermore, a food frequency questionnaire and the effect of oral antibiotic rifaximin on plasma TMAO concentrations were explored in these 40 patients. We found CVID patients to have higher plasma concentrations of TMAO than controls (TMAO 5.0 [2.9-8.6] vs. 3.2 [2.2-6.3], p = 0.022, median with IQR). The TMAO concentration correlated positively with tumor necrosis factor (p = 0.008, rho = 0.26), interleukin-12 (p = 0.012, rho = 0.25) and LPS (p = 0.034, rho = 0.21). Dietary intake of meat (p = 0.678), fish (p = 0.715), egg (p = 0.138), dairy products (p = 0.284), and fiber (p = 0.767) did not significantly impact on the TMAO concentrations in plasma, nor did a 2-week course of the oral antibiotic rifaximin (p = 0.975). However, plasma TMAO concentrations correlated positively with gut microbial abundance of Gammaproteobacteria (p = 0.021, rho = 0.36). Bacterial gene CntA was present in significantly more CVID samples (75%) than controls (53%), p = 0.020, potentially related to the increased abundance of Gammaproteobacteria in these samples. The current study demonstrates that elevated TMAO concentrations are associated with systemic inflammation and increased gut microbial abundance of Gammaproteobacteria in CVID patients, suggesting that TMAO could be a link between gut microbial dysbiosis and systemic inflammation. Gut microbiota composition could thus be a potential therapeutic target to reduce systemic inflammation in CVID.
Subject(s)
Common Variable Immunodeficiency/blood , Gastrointestinal Microbiome , Methylamines/blood , Adult , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Bacteria/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biomarkers/blood , Carnitine/metabolism , Common Variable Immunodeficiency/drug therapy , Common Variable Immunodeficiency/immunology , Common Variable Immunodeficiency/microbiology , Diet , Feces/microbiology , Female , Gastrointestinal Microbiome/genetics , Humans , Immunoglobulin A, Secretory/blood , Inflammation , Lipopolysaccharides/blood , Male , Metabolic Networks and Pathways , Methylamines/metabolism , Middle Aged , Rifaximin/administration & dosageABSTRACT
Introduction: Previous studies have shown 37.8 kDa pili subunit protein of Vibrio cholerae and 49.8 kDa pili subunit protein of Shigella flexneri can act as an adhesion molecule to initiate infection. These molecules also have the ability to agglutinate blood. The present study assessed mucosal and systemic immunity following vaccination using 37.8 kDa V. cholerae and protection against S. flexneri. Subjects and Methods: Haemagglutination test was performed after purification of V. cholerae protein, followed by an anti-haemagglutination test. The intestinal weight and colony count were used to validate the protective effect on balb/c mice which were divided into the naive group, Shigella-positive control group, Vibrio-positive control group, V. cholerae infected-Vibrio-vaccinated group and S. flexneri-infected-Vibrio-vaccinated group. Th17, Treg, interleukin (IL) IL-17A, ß-defensin and secretory-immunoglobulin A (s-IgA) were also measured to determine the systemic and mucosal immunity after vaccination. Results: The haemagglutination and anti-haemagglutination tests showed that the 37.8 kDa protein could inhibit 49.8 kDa of the S. flexneri pili subunit. Decreased intestinal weight and colony count of vaccinated group compared to naive group also support cross reaction findings. Vaccination also generates higher level of Th17, Treg, IL-17A, ß-defensin and s-IgA significantly. Conclusions: 37.8 kDa subunit pili can act as a homologous vaccine candidate to prevent V. cholerae and S. flexneri infection.
Subject(s)
Antigens, Bacterial/immunology , Dysentery, Bacillary/immunology , Fimbriae Proteins/immunology , Fimbriae, Bacterial/immunology , Vaccination , Animals , Antibodies, Bacterial/blood , Antigens, Bacterial/administration & dosage , Dysentery, Bacillary/prevention & control , Immunoglobulin A, Secretory/blood , Interleukin-17/analysis , Mice, Inbred BALB C , Shigella flexneri , T-Lymphocytes, Regulatory/immunology , Th17 Cells/immunology , Vibrio cholerae/immunology , beta-Defensins/analysisABSTRACT
(-)-Epigallocatechin-3-gallate (EGCG) is the most abundant polyphenolic compound present in green tea and has been shown to possess bio-activities. In this study, we investigated the protective effects of EGCG against restraint stress (RS)-induced liver injury and immunosuppression. EGCG (10, 20 and 40 mg/kg) was orally administered to mice daily for 7 days before modeling the restraint stress. lood, liver and broncho-alveolar lavage fluid (BALF) samples were collected and tested. We found that EGCG significantly reduced the release of stress hormones to weak restraint stress response. EGCG effectively improved hepatic damage by decreas the serum levels of alanine aminotransaminase (ALT) and aspartate transaminase (AST) in restraint-challenged mice. Furthermore, EGCG also significantly prevented the release of H2O2, NOS and 8-isoprostane, and reduced the levels of interleukin (IL)-1ß, IL-2,and IL-6 restrained mice. EGCG can normal the level of cytochrome P450 (CYP450) 1A2, 2D22, 2E1 and 3A11 that induced by restraint stress., the inhibition status of T cells subsets in serum and gA in BALF were significantly relieved EGCG pretreatment. Taken together, our data suggest that EGCG possesse hepatic- and immune-protective properties against restraint stress through its anti-oxidant, anti-inflammatory and immunomodulatory activities.
Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Catechin/analogs & derivatives , Cytochrome P-450 Enzyme System/metabolism , Immunologic Factors/pharmacology , Liver/drug effects , Restraint, Physical , Stress, Physiological/drug effects , Stress, Psychological/drug therapy , Animals , Biomarkers/blood , Biotransformation , Catechin/pharmacology , Cytokines/blood , Disease Models, Animal , Female , Immunoglobulin A, Secretory/blood , Inflammation Mediators/blood , Isoenzymes , Liver/enzymology , Liver/pathology , Male , Mice, Inbred ICR , Oxidative Stress/drug effects , Stress, Psychological/enzymology , Stress, Psychological/etiology , Stress, Psychological/immunology , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolismABSTRACT
BACKGROUND: Tattooing has been practiced globally for thousands of years. From an evolutionary perspective, this tradition seems counterintuitive because it is a dermal injury that risks infection. Previous research indicates tattooing may habituate the immune system for subsequent stress, as with exercise or vaccination, an important benefit in high-risk areas. Visible injuries through tattooing may be a form of costly honest signaling-consciously or unconsciously drawing attention to immunological quality. OBJECTIVES: We tested this habituation effect of tattooing in American Samoa, where its practice is common and extensive and infectious disease rates high. We hypothesized that people with more tattoo experience would have enhanced immune response related to the stress of being tattooed. We compared total and rate of tattoo experience to determine if tattooing is more analogous to exercise or vaccination. METHODS: We measured secretory immunoglobulin A (SIgA), cortisol, C-reactive protein (CRP), and tattoo experience in 25 adults receiving tattoos. We compared post-tattoo SIgA to total and rate of tattoo experience using analyses of covariance, controlling for pre-tattoo SIgA, tattoo duration, age, marital status, and stress and baseline health (cortisol, CRP, body mass index, and cigarette use). RESULTS: Post-tattoo SIgA positively correlated with total tattoo experience (P < .05). Furthermore, when dichotomized by experience, participants with low tattoo experience showed little to no stress-related immune change, whereas high-experience participants exhibited elevated SIgA, suggesting habituation to repeated tattooing. CONCLUSIONS: The historical and cultural popularity of tattooing may be partly due to honest information tattoos convey about adaptive biology, similar to physical benefits of exercise.
Subject(s)
C-Reactive Protein/metabolism , Cultural Evolution , Hydrocortisone/blood , Immunity , Immunoglobulin A, Secretory/blood , Tattooing/psychology , Adult , Aged , American Samoa , Female , Humans , Male , Middle Aged , Young AdultABSTRACT
Bovine viral diarrhea caused by bovine viral diarrhea virus (BVDV) is an important disease in cattle, resulting in significant economic losses to the cattle industry worldwide. In order to develop an effective vaccine against BVDV infection, we constructed a dendritic cell (DC)-targeting oral probiotic vaccine (pPG-E2-DCpep/LC W56) using Lactobacillus casei as antigen delivery carrier to express BVDV glycoprotein E2 fused with DC-targeting peptide, and the immunogenicity of orally administered probiotic vaccine was evaluated in mice model. Our results showed that after immunization with the probiotic vaccine, significantly levels of antigen-specific sera IgG and mucosal sIgA antibodies (p < 0.05) with BVDV-neutralizing activity were induced in vivo. Challenge experiment showed that pPG-E2-DCpep/LC W56 can provide effective immune protection against BVDV, and BVDV could be effectively cleared from the intestine of immunized mice post-challenge. Moreover, the pPG-E2-DCpep/LC W56 could efficiently activate DCs in the intestinal Peyer's patches, and significantly levels of lymphoproliferative responses, Th1-associated IFN-γ, and Th2-associated IL-4 were observed in mice immunized with pPG-E2-DCpep/LC W56 (p < 0.01). Our results clearly demonstrate that the probiotic vaccine could efficiently induce anti-BVDV mucosal, humoral, and cellular immune responses via oral immunization, indicating a promising strategy for the development of oral vaccine against BVDV.
Subject(s)
Bovine Virus Diarrhea-Mucosal Disease/prevention & control , Dendritic Cells/immunology , Diarrhea Viruses, Bovine Viral/immunology , Drug Carriers , Lacticaseibacillus casei/genetics , Viral Envelope Proteins/immunology , Viral Vaccines/immunology , Administration, Oral , Animals , Antibodies, Neutralizing/analysis , Antibodies, Neutralizing/blood , Antibodies, Viral/analysis , Antibodies, Viral/blood , Cattle , Dendritic Cells/metabolism , Diarrhea Viruses, Bovine Viral/genetics , Disease Models, Animal , Genetic Vectors , Immunoglobulin A, Secretory/blood , Immunoglobulin G/blood , Lacticaseibacillus casei/metabolism , Mice , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/metabolism , Treatment Outcome , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism , Viral Vaccines/administration & dosage , Viral Vaccines/geneticsABSTRACT
AIM: To determine the protective capacity against Salmonella infection in mice of the cell-free fraction (postbiotic) of fermented milk, produced at laboratory and industrial level. METHODS AND RESULTS: The proteolytic activity (PA) of 5 commercial cultures and 11 autochthonous Lactobacillus strains was evaluated. The DSM-100H culture displayed the highest PA and it was selected for further studies. The capacity of the postbiotics produced by pH-controlled fermentation to stimulate the production of secretory IgA in faeces and to protect mice against Salmonella infection was evaluated. A significant increase in secretory IgA in faeces of mice fed 14 days the postbiotic obtained at the laboratory (F36) was detected compared to control animals. A significantly higher survival was observed in mice fed the F36 and the FiSD (industrial product) compared to controls. CONCLUSION: The postbiotics obtained showed immunomodulatory and protective capacity against Salmonella infection in mice. SIGNIFICANCE AND IMPACT OF THE STUDY: The pH-controlled milk fermentation by the proteolytic DSM-100H culture could be a suitable strategy to obtain a food ingredient to be added to a given food matrix, not adequate to host viable cells of probiotics, to confer it enhanced functionality and thus expand the functional food market.
Subject(s)
Animal Feed/microbiology , Cultured Milk Products/microbiology , Functional Food/microbiology , Probiotics/metabolism , Salmonella Infections/prevention & control , Animals , Immunoglobulin A, Secretory/blood , Lactobacillus/metabolism , Mice , ProteolysisABSTRACT
In order to evaluate the sIgA-ELISA method reported previously for differentiating Mycoplasma hyopneumoniae (M. hyopneumoniae) infected from vaccinated pigs, dynamics of anti-M. hyopneumoniae secretory IgA (sIgA) antibody secretion in nasal mucus and IgG antibodies in serum from 10 pigs experimentally infected with M. hyopneumoniae or vaccinated with an inactivated vaccine were examined using sIgA-ELISA and a commercial M. hyopneumoniae antibody detection kit (IgG-ELISA), respectively. In addition, nasal swabs and serum samples from 2368 pigs of different ages originating from 10 pig farms with different M. hyopneumoniae infection and vaccination status were examined using the two ELISA. In the experimental model, anti-M. hyopneumoniae IgG antibodies were detected in both, the challenge group and the vaccine group. Anti-M. hyopneumoniae sIgA antibodies were detected in the challenge group from 7 days post challenge onwards, but not in the vaccine group. According to the data obtained from pig farms maintaining administration of inactivated vaccine, the prevalence of anti-M. hyopneumoniae sIgA antibody positive pigs was significantly lower than that of IgG antibody positive pigs. In non-vaccinating herds, the prevalence of sIgA antibodies was correlated with the severity of clinical symptoms typical for porcine enzootic pneumonia. In all suckling pigs, no matter vaccinated or not, the prevalence of anti-M. hyopneumoniae sIgA antibody positives was significantly lower than that of IgG antibody positives. These results prove that the sIgA-ELISA is a valuable method enabling the surveillance of M. hyopneumoniae infections in pig herds without interference due to maternally derived antibodies or antibodies induced by administration of inactivated vaccines.
Subject(s)
Enzyme-Linked Immunosorbent Assay/veterinary , Immunoglobulin A, Secretory/blood , Mycoplasma hyopneumoniae/classification , Pneumonia of Swine, Mycoplasmal/prevention & control , Swine Diseases/prevention & control , Animals , Female , Male , Mycoplasma hyopneumoniae/immunology , Mycoplasma hyopneumoniae/isolation & purification , Pneumonia of Swine, Mycoplasmal/diagnosis , Pneumonia of Swine, Mycoplasmal/microbiology , Swine , Swine Diseases/microbiology , Vaccination/veterinary , Vaccines, Inactivated/immunologyABSTRACT
Rheumatoid arthritis (RA) is a chronic inflammatory disease where serum analysis of anti-citrullinated peptide/protein antibodies (ACPA) is an important diagnostic/prognostic tool. Levels and changes of ACPA in RA patients have been studied previously in relation to disease course and therapy response, but less is known regarding ACPA isotype changes in early RA. Hence, recent-onset RA patients (n = 231) were subjected to a 3-year clinical and radiological follow-up. Serum samples were serially collected and ACPA isotypes were analysed using the second-generation cyclic citrullinated peptide (CCP) as capture antigen. Changes in ACPA isotype levels and status were related to disease course and pharmacotherapy. At inclusion, 74% of the patients tested positive for ACPA IgG; 55% for immunoglobulin (Ig)A, 37% for secretory IgA (SIgA) and 35% for IgM. The proportion of positive patients decreased significantly at follow-up regarding ACPA SIgA, IgM and IgA. During the initial 3 months, reduction of the 28-joint disease activity score (DAS28) correlated with reduced levels of ACPA IgG (Rho = 0·242, P = 0·003), IgA (Rho = 0·260, P = 0·008), IgM (Rho = 0·457, P < 0·001) and SIgA (Rho = 0·402, P < 0·001). Levels of ACPA SIgA (P = 0·008) and IgM (P = 0·021) decreased significantly among patients with good response to treatment, which was not seen regarding ACPA IgA or IgG. Changes in ACPA isotype levels were not associated with radiographic damage. In conclusion, ACPA SIgA and IgM declined rapidly upon anti-rheumatic therapy and correlated with decreased disease activity in recent-onset RA. This may indicate that down-regulation of mucosal immunity to citrullinated proteins/peptides and recruitment of new B cells are key features of therapy responses in early RA.
Subject(s)
Arthritis, Rheumatoid/immunology , Autoantibodies/blood , Immunoglobulin A, Secretory/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Peptides, Cyclic/immunology , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Autoantibodies/immunology , Disease Progression , Female , Humans , Immunoglobulin A, Secretory/drug effects , Immunoglobulin A, Secretory/immunology , Immunoglobulin G/immunology , Immunoglobulin M/drug effects , Immunoglobulin M/immunology , Longitudinal Studies , Male , Middle Aged , Surveys and QuestionnairesABSTRACT
Based on previous studies about microflora regulation and immunity enhancement activities of polysaccharides from Codonopsis pilosula Nannf. var. modesta (Nannf.) L. T. Shen (CPP), there is little study on intestinal mucosal immunity, which is a possible medium for contacting microflora and immunity. In the present study, the BALB/c mice were divided into five groups (eight mice in each group), including a normal group (Con), a model control group (Model), and model groups that were administered CPP (50, 100, 200 mg/kg/d) orally each day for seven days after intraperitoneal injection of 60 mg/kg BW/d cyclophosphamide (CP) for three days. CPP recovered the spleen index and restored the levels of IFN-γ, IL-2, IL-10, as well as serum IgG. In addition, it elevated ileum secretory immunoglobulin A (sIgA), the number of Lactobacillus and acetic acid content in cecum. These results indicated that CPP plays an important role in the protection against immunosuppression, especially mucosa immune damage, and the inhibition of pathogenic bacteria colonization, which could be considered a potential natural source of immunoregulator.
Subject(s)
Codonopsis/chemistry , Cyclophosphamide/pharmacology , Gastrointestinal Microbiome/drug effects , Immunity/drug effects , Immunocompromised Host , Immunologic Factors/pharmacology , Immunosuppressive Agents/pharmacology , Polysaccharides/pharmacology , Animals , Cytokines/blood , Immunity, Mucosal/drug effects , Immunoglobulin A, Secretory/blood , Immunoglobulin A, Secretory/immunology , Liver/drug effects , Liver/immunology , Mice , Spleen/drug effects , Spleen/immunology , Thymus Gland/drug effects , Thymus Gland/immunologyABSTRACT
Antigen-specific immunoglobulin (Ig) A plays a major role in host defense against infections in gut mucosal tissue. Follicular helper T (Tfh) cells are located in germinal centers and promote IgA production via interactions with germinal center B cells. Several studies have demonstrated that some lactic acid bacteria (LAB) strains activate the host's acquired immune system, inducing IgA secretion in the intestine. However, the precise molecular mechanisms underlying the effects of LAB on IgA production and Tfh cells are not fully resolved. Lactobacillus paracasei MCC1849 is a probiotic strain isolated from the intestine of a healthy adult. In this study, we investigated the effects of orally administered heat-killed MCC1849 on IgA production in the intestine and on Tfh cell induction in vivo. We found that orally administered MCC1849 induced antigen-specific IgA production in the small intestine, serum and lungs. We also observed that MCC1849 increased the proportion of IgA+ B cells and Tfh cells in Peyer's patches (PPs). In addition, MCC1849 increased the gene expression of IL-12p40, IL-10, IL-21, STAT4 and Bcl-6 associated with Tfh cell differentiation. These results suggest that orally administered MCC1849 enhances antigen-specific IgA production and likely affects Tfh cell differentiation in PPs.
Subject(s)
Immunoglobulin A, Secretory/metabolism , Lacticaseibacillus paracasei/immunology , T-Lymphocytes, Helper-Inducer/immunology , Administration, Oral , Animals , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Cell Differentiation , Cytokines/analysis , Cytokines/metabolism , Hot Temperature , Immunoglobulin A, Secretory/blood , Influenza A Virus, H1N1 Subtype/pathogenicity , Intestine, Small/metabolism , Lung/metabolism , Male , Mice , Mice, Inbred BALB C , Orthomyxoviridae Infections/prevention & control , Ovalbumin/immunology , Peyer's Patches/metabolism , Probiotics/administration & dosage , Proto-Oncogene Proteins c-bcl-6/metabolism , T-Lymphocytes, Helper-Inducer/cytology , T-Lymphocytes, Helper-Inducer/metabolismABSTRACT
Background: A 10% cocoa-enriched diet influences immune system functionality including the prevention of the antibody response and the induction of lower immunoglobulin (Ig) concentrations. However, neither cocoa polyphenols nor cocoa fiber can totally explain these immunoregulatory properties. Objectives: This study aimed to establish the influence of cocoa theobromine in systemic and intestinal Ig concentrations and to determine the effect of cocoa or theobromine feeding on lymphoid tissue lymphocyte composition. Methods: Three-week-old female Lewis rats were fed either a standard diet (AIN-93M; RF group), a 10% cocoa diet (CC group), or a 0.25% theobromine diet (the same amount provided by the cocoa diet; TB group) in 2 separate experiments that lasted 19 (experiment 1) or 8 (experiment 2) d. Serum IgG, IgM, IgA, and intestinal secretory IgA (sIgA) concentrations were determined. In addition, at the end of experiment 2, thymus, mesenteric lymph node (MLN), and spleen lymphocyte populations were analyzed. Results: Both CC and TB groups in experiments 1 and 2 showed similar serum IgG, IgM, and IgA and intestinal sIgA concentrations, which were lower than those in the RF group (46-98% lower in experiment 1 and 23-91% lower in experiment 2; P < 0.05). In addition, in experiment 2, the cocoa and theobromine diets similarly changed the thymocyte composition by increasing CD4-CD8- (+133%) and CD4+CD8- (+53%) proportions (P < 0.01), changed the MLN composition by decreasing the percentage of T-helper (Th) lymphocytes (-3%) (P = 0.015), and changed the spleen composition by increasing the proportion of Th lymphocytes (+9%) (P < 0.001) after 1 wk of diet treatment. Conclusions: The theobromine in cocoa plays an immunoregulatory role that is responsible for cocoa's influence on both systemic and intestinal antibody concentrations and also for modifying lymphoid tissue lymphocyte composition in young healthy Lewis rats. The majority of these changes are observed after a single week of being fed a diet containing 0.25% theobromine.
Subject(s)
Cacao/chemistry , Diet , Immunoglobulins/metabolism , Immunologic Factors/pharmacology , Plant Extracts/pharmacology , T-Lymphocytes, Helper-Inducer/metabolism , Theobromine/pharmacology , Animals , CD4-CD8 Ratio , Chocolate , Feeding Behavior , Immunoglobulin A, Secretory/blood , Immunoglobulin A, Secretory/metabolism , Immunoglobulin G/blood , Immunoglobulin M/blood , Immunoglobulins/blood , Intestines/drug effects , Intestines/immunology , Lymphoid Tissue/drug effects , Lymphoid Tissue/metabolism , Rats, Inbred LewABSTRACT
STING (stimulator of interferon genes) is a cytosolic sensor for cyclic dinucleotides and also an adaptor molecule for intracellular DNA receptors. Although STING has important functions in the host defense against pathogens and in autoimmune diseases, its physiological relevance in intestinal homeostasis is largely unknown. In this study, we show that STING-/- mice presented defective protective mechanisms of intestinal mucosa, including decreased number of goblet cells, diminished mucus production, and lower levels of secretory IgA, when compared with wild-type (WT) mice. Fecal content and microbiota DNA could activate STING, indicating a role of this molecule in gut. Microbiota composition was altered in STING-/- mice toward a more inflammatory profile, evidencing a reduction in the Allobacolum and Bifidobacterium groups along with increase in Disulfovibrio bacteria. Absence of STING lead to decrease in induced intraepithelial lymphocytes (IEL) and to increase in group 1 innate lymphoid cell (ILC1) as well as ILC3 frequencies and decrease in ILC2 in the colon. Development and function of Foxp3+ and LAP+ regulatory T cells were also compromised in STING-/- mice. Moreover, these mice were highly susceptible to dextran sodium sulfate-induced colitis, T-cell-induced colitis, and enteric Salmonella typhimurium infection when compared with WT animals. Therefore, our results identify an important role of STING in maintaining gut homeostasis and also a protective effect in controlling gut inflammation.
Subject(s)
Colitis/immunology , Gastrointestinal Microbiome/physiology , Intestinal Mucosa/immunology , Intestines/physiology , Lymphocytes/immunology , Membrane Proteins/metabolism , Salmonella Infections/immunology , Salmonella typhimurium/immunology , T-Lymphocytes, Regulatory/immunology , Animals , Colitis/chemically induced , Colitis/genetics , Dextran Sulfate , Female , Forkhead Transcription Factors/metabolism , Homeostasis , Immunity, Innate , Immunoglobulin A, Secretory/blood , Male , Membrane Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Salmonella Infections/genetics , Th1 Cells/immunologyABSTRACT
Secretory immunoglobulins have a critical role in defense of the gastrointestinal tract and are known to act by preventing bacterial acquisition. A stringent murine model of bacterial infection with Salmonella enterica Typhimurium was used to examine protection mediated by oral passive immunization with human plasma-derived polyreactive IgA and IgM antibodies (Abs) reconstituted as secretory-like immunoglobulins (SCIgA/M). This reagent has been shown to trigger Salmonella agglutination and to limit the entry of bacterium into intestinal Peyer's patches via immune exclusion. We now demonstrate that upon administration into ligated intestinal loops, SCIgA/M properly anchors in the mucus and is protected from degradation to a better extent that IgA/M or IgG. Moreover, prophylactic oral administration of SCIgA/M before intragastric infection of mice with a virulent strain of S. enterica Typhimurium allows to protect infected animals, as reflected by reduced colonization of both mucosal and systemic compartments, and conserved integrity of intestinal tissues. In comparison with IgA/M or IgG administration, SCIgA/M provided the highest degree of protection. Moreover, such protective efficacy is also observed after therapeutic oral delivery of SCIgA/M. Either prophylactic or therapeutic treatment with passively delivered SCIgA/M ensured survival of up to 50% of infected mice, while untreated animals all died. Our findings unravel the potential of oral passive immunization with plasma-derived polyreactive SCIgA/M Abs to fight gastrointestinal infections.
Subject(s)
Immunization, Passive/methods , Immunoglobulin A, Secretory/administration & dosage , Immunoglobulin M/administration & dosage , Salmonella Infections/therapy , Salmonella typhimurium/immunology , Administration, Oral , Animals , Disease Models, Animal , Female , Humans , Immunoglobulin A, Secretory/blood , Immunoglobulin A, Secretory/isolation & purification , Immunoglobulin M/blood , Immunoglobulin M/isolation & purification , Intestinal Mucosa/immunology , Intestinal Mucosa/microbiology , Mice , Mice, Inbred BALB C , Peyer's Patches/immunology , Peyer's Patches/microbiology , Plasma/immunology , Salmonella Infections/immunology , Salmonella Infections/microbiology , Salmonella typhimurium/pathogenicity , Treatment OutcomeSubject(s)
B-Lymphocytes/immunology , Immunoglobulin A, Secretory/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Immunotherapy, Adoptive/adverse effects , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Urinary Tract Infections/immunology , Urinary Tract Infections/microbiology , Antigens, CD19/analysis , Antimetabolites, Antineoplastic/therapeutic use , Bacteriuria , Child , Clofarabine/therapeutic use , Cytarabine/therapeutic use , Escherichia coli/immunology , Escherichia coli Infections/immunology , Female , Humans , Immunotherapy, Adoptive/methods , Lymphocyte Count , Neoplasm Recurrence, Local/drug therapy , Proteus Infections/immunology , Proteus mirabilis/immunologyABSTRACT
CONTEXT: Salivary antibodies may act as non-invasive marker of systemic immunity enabling assessment of vaccination and protection against bacterial infections. OBJECTIVE: To assess if levels of anti-pneumococcal (Pn) antibodies in saliva reflect concentrations in serum and determine whether saliva can accurately identify protective concentrations in serum. METHODS: IgG, IgA and IgM antibody levels in paired saliva and serum samples were measured against 12 Pn polysaccharide antigens in 72 healthy adults. RESULTS: Antibody levels in saliva correlated positively with serum across immunoglobulin classes, most strongly for IgA. Individuals who had protective antibody levels in serum demonstrated significantly higher IgG and IgA salivary antibody concentrations/secretion rates. Salivary IgG and IgA Pn antibodies were able to distinguish between those with/without protective levels in serum for the majority of serotypes. Salivary IgM antibodies were not able to differentiate protective status. Median IgG and IgA Pn salivary parameters were able to identify individuals who had protective levels in serum on ≥8/12 serotypes with moderate accuracy: median IgA secretion rates provided the best sensitivity (73%) and specificity (71%). CONCLUSIONS: These findings suggest that IgG and IgA Pn specific antibodies in saliva may be useful surrogate markers of antibody status in serum.